The Complete Response of a Renal Cell Carcinoma Metastatic to Brain, Lungs, and Liver to Second-Line Nivolumab: A Case Report

Metastatic renal cell carcinoma (RCC) is a therapeutic challenge to clinicians since it shows significant resistance to chemotherapy and radiation therapy. With the introduction of immunotherapy, the treatment paradigm for RCC has evolved. Here, we describe the case of a 55-year-old male who present...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghpanah, Mahsa, Azimi, Armin, Fadavi, Pedram, Bagheri, Seyed Morteza, Arefpour, Amir Mohammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615099/
https://www.ncbi.nlm.nih.gov/pubmed/36321052
http://dx.doi.org/10.7759/cureus.29680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615099/
https://www.ncbi.nlm.nih.gov/pubmed/36321052
http://dx.doi.org/10.7759/cureus.29680

Ejemplares similares